- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Pernix Therapeutics Holdings Inc+ Add to Watchlist
PTX:US9.0500 USD 0.2800 3.19%
As of 17:10:00 ET on 12/24/2014.
Company Profile for Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.
Pernix Therapeutics Holdings Inc
Key Executives for Pernix Therapeutics Holdings Inc (PTX)
|Douglas Drysdale "Doug"Chairman/President/CEO||Sanjay S PatelChief Financial Officer|
|Terence S Novak "Terry"Chief Operating Officer||Brian T DorseySenior VP:Pharmaceutical Dev|
|Rick ShalabySenior VP:Sales||Tracy S CliffordVP:Accounting/Treasurer/Secy|